Diabetes Clinical Trials in Chicago

Showing 441-460 of 509 trials

Evaluation of Low Source of Signal in SCOUT DS

NCT01339637

The overall objective of this study is to increase the number of dark skin tone individuals in the data set and evaluate if this increase in dark skin tone data has an impact on the accuracy of the SCOUT DS Diabetes Risk Score (DRS).

Metabolic SyndromeImpaired Glucose ToleranceGestational Diabetes

VeraLight, Inc.196 participantsStarted Apr 2011

Birmingham, Alabama, United States • Atlanta, Georgia, United States • Chicago, Illinois, United States +2 more locations

COMPLETED2.2 miles

Screening for Early Evidence of Diabetes

NCT00614783

This is a pivotal study to determine the accuracy of a new device (SCOUT) in screening persons for pre-diabetes or diabetes. SCOUT will be compared to the standard screening test (Fasting Plasma Glucose), using the Oral Glucose Tolerance Test as the reference standard. SCOUT uses a rapid, noninvasive, light-based technology to measure the concentration of chemicals in the skin called advanced glycation endproducts (AGEs). Several studies have demonstrated that AGEs accumulate in skin faster in individuals with poor control of blood sugar. Persons will be eligible for the study if they are 'at risk' for diabetes based on their age and other risk factors as defined by the American Diabetes Association.

Diabetes Mellitus, Type 2

VeraLight, Inc.3,478 participantsStarted May 2007

Huntsville, Alabama, United States • San Diego, California, United States • San Diego, California, United States +12 more locations

Evaluation of Low Source of Signal in SCOUT DS

Screening for Early Evidence of Diabetes

Diabetes Trials in Other Cities

A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Follow-Up Study for Exubera

Effect of Platelet Concentrate in Treatment of Diabetic Ulcers

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

Study of VI-0521 Compared to Placebo in Treatment of Diabetes and Obesity in Adults With Obesity-Related Co-Morbid Conditions

Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes

Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis

Testing the Developmental Origins Hypothesis

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

A Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney Function

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease

Multicenter Worksite Nutrition Study

Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment

Other Conditions in Chicago